Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.
暂无分享,去创建一个
E. Topol | P. Serruys | S. Ellis | R. Schwartz | A. Lincoff | D. Holmes | W. J. van der Giessen | H. V. van Beusekom | P. Serruys | Stephen G. Ellis | S. Ellis
[1] C A Homsy,et al. Bio-compatibility in selection of materials for implantation. , 1970, Journal of biomedical materials research.
[2] E. J. Frazza,et al. A new absorbable suture. , 1971, Journal of biomedical materials research.
[3] E. Ethridge,et al. Biomaterials—The Interfacial Problem , 1975 .
[4] J M Brady,et al. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. , 1977, Journal of biomedical materials research.
[5] D. Lyman,et al. Compliance as a factor effecting the patency of a copolyurethane vascular graft. , 1978, Journal of biomedical materials research.
[6] D. Lyman,et al. Effect of elasticity of prosthetic wall on patency of small-diameter arterial prostheses. , 1979, Surgical forum.
[7] C. G. Gebelein. Polymeric materials and artificial organs , 1984 .
[8] Silicones in Artificial Organs , 1984 .
[9] F. Moatamed,et al. The intracellular degradation of poly(ε-caprolactone) , 1985 .
[10] J. Heller,et al. In vitro and in vivo release of levonorgestrel from poly(ortho esters): I. Linear polymers , 1985 .
[11] Arthur J. Coury,et al. Medical applications of implantable polyurethanes: current issues , 1987 .
[12] A. Sumner,et al. Prosthetic nerve grafts: a resorbable tube as an alternative to autogenous nerve grafting. , 1987, The Journal of hand surgery.
[13] David F. Williams,et al. On the biodegradation of poly-β-hydroxybutyrate (PHB) homopolymer and poly-β-hydroxybutyrate-hydroxyvalerate copolymers , 1987 .
[14] N. Chegini,et al. A comparative scanning electron microscopic study on degradation of absorbable ligating clips in vivo and in vitro. , 1988, Journal of biomedical materials research.
[15] J. J. Grote,et al. Effect of implantation site on phagocyte/polymer interaction and fibrous capsule formation. , 1988, Biomaterials.
[16] J. J. Grote,et al. Biocompatibility of six elastomers in vitro. , 1988, Journal of biomedical materials research.
[17] S. Davis,et al. Polyhydroxybutyrate as a drug carrier. , 1989, Critical reviews in therapeutic drug carrier systems.
[18] Vascular stents and atherosclerosis. , 1989, Circulation.
[19] Stenting of coronary arteries. Are we the sorcerer's apprentice? , 1989, European heart journal.
[20] R. Langer,et al. Biodegradable polymers as drug delivery systems , 1990 .
[21] J. J. Grote,et al. Biocompatibility of a polyether urethane, polypropylene oxide, and a polyether polyester copolymer. A qualitative and quantitative study of three alloplastic tympanic membrane materials in the rat middle ear. , 1990, Journal of biomedical materials research.
[22] C. G. Pitt. Poly-ε-caprolactone and its copolymers , 1990 .
[23] J. Benoit,et al. A physicochemical study of the morphology of progesterone-loaded microspheres fabricated from poly(D,L-lactide-co-glycolide). , 1991, Journal of biomedical materials research.
[24] Julio C. Palmaz,et al. Clinical Experience With the Palmaz‐Schatz Coronary Stent: Initial Results of a Multicenter Study , 1991, Circulation.
[25] P. Serruys,et al. Coronary Stenting With a New, Radiopaque, Balloon‐Expandable Endoprosthesis in Pigs , 1991, Circulation.
[26] O. Böstman. Absorbable implants for the fixation of fractures. , 1991, The Journal of bone and joint surgery. American volume.
[27] E. Topol,et al. Implantable devices in the coronary artery from metal to genes. , 1991, Trends in cardiovascular medicine.
[28] R. Wilensky,et al. Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplasty. , 1991, American Heart Journal.
[29] T. V. How,et al. Mechanical Properties of Arteries and Arterial Grafts , 1992 .
[30] R E Vlietstra,et al. Percutaneous Polymeric Stents in Porcine Coronary Arteries: Initial Experience With Polyethylene Terephthalate Stents , 1992, Circulation.
[31] Willem J. van der Giessen,et al. Coronary stenting with polymer-coated and uncoated self-expanding endoprostheses in pigs , 1992 .
[32] D. Cox,et al. Effect of local delivery of heparin and methotrexate on neointimal proliferation in stented porcine coronary arteries , 1992 .
[33] P D Verdouw,et al. Development of a polymer endovascular prosthesis and its implantation in porcine arteries. , 1992, Journal of interventional cardiology.
[34] R. Wilensky,et al. Methods and devices for local drug delivery in coronary and peripheral arteries. , 1993, Trends in cardiovascular medicine.
[35] Epic Investigators,et al. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.
[36] D. Hathaway,et al. Biodegradable microspheres containing a colchicine analogue inhibit DNA synthesis in vascular smooth muscle cells. , 1994, Circulation.
[37] R. Califf,et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months , 1994, The Lancet.
[38] W Rutsch,et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.
[39] P. Teirstein,et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.
[40] E J Topol,et al. Caveats about elective coronary stenting. , 1994, The New England journal of medicine.
[41] P Hall,et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. , 1995, Circulation.
[42] B. Meier,et al. Coronary stenting without anticoagulation. , 1995, Catheterization and cardiovascular diagnosis.
[43] E. Edelman,et al. Endovascular stent design dictates experimental restenosis and thrombosis. , 1995, Circulation.
[44] P D Verdouw,et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. , 1996, Circulation.